Earnings Outlook For Regulus Therapeutics – Regulus Therapeutics (NASDAQ:RGLS)  Benzinga

IDEAYA Biosciences’s Return On Capital Employed Insights – IDEAYA Biosciences (NASDAQ:IDYA)  Benzinga

Amyris’ Debt Overview – Amyris (NASDAQ:AMRS)  Benzinga

Disruptive Ad Tech Company Thumzup Launches Reg A+ Offering …  MarTech Series

Disruptive Ad Tech Company Thumzup® Launches Reg A+ Offering …  GlobeNewswire